Sanofi to continue diversification, eyes acquisitions: Handelsblatt

FRANKFURT (Reuters) - Sanofi's new CEO will continue its strategy of diversifying beyond new drug development, possibly through acquisitions, the French drugmaker's interim chief executive said.

from Reuters: Deals http://ift.tt/1GcnbeF